| 臺大學術典藏 |
2021-07-26T10:04:02Z |
Maternal hypercholesterolemia exacerbates atherosclerosis lesions in female offspring through potentiating macrophage polarization toward an inflammatory M1 phenotype
|
Chen S.-Y;Chen Y.-Z;Lee Y.-J;Jiang C.-L;Lu S.-C;Lin F.-J.; Chen S.-Y; Chen Y.-Z; Lee Y.-J; Jiang C.-L; Lu S.-C; Lin F.-J.; FU-JUNG LIN |
| 臺大學術典藏 |
2021-07-19T08:23:18Z |
Clinical pharmacy service and international collaboration: Model and experience from a medical center in Taiwan
|
Wu C.-C.; Lin F.-J.; Lin S.-W.; YUNN-FANG HO; Huang C.-F.; Shen L.-J.; Wu F.-L.L. |
| 臺大學術典藏 |
2021-07-08T08:19:42Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.;Kao H.-L.;Wang C.-C.;Shin Yi Lin;Lin F.-J.; Wang Y.-H.; Kao H.-L.; Wang C.-C.; SHIN YI LIN; Lin F.-J. |
| 臺大學術典藏 |
2021-07-08T08:19:41Z |
Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study
|
Wei Y.;Lin F.-J.;Shin Yi Lin;Wang C.-C.; Wei Y.; Lin F.-J.; SHIN YI LIN; Wang C.-C. |
| 臺大學術典藏 |
2021-07-08T08:19:39Z |
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation and valvular heart disease
|
Li H.-J.; SHIN YI LIN; Lin F.-J.; Hung C.-S.; Wang C.-C. |
| 臺大學術典藏 |
2021-07-08T08:19:38Z |
Risk of Intracranial Hemorrhage With Concomitant Use of Antidepressants and Nonsteroidal Anti-inflammatory Drugs: A Nested Case-Control Study
|
Hou P.-C.; Lin F.-J.; SHIN YI LIN; Hwang T.-J.; Wang C.-C. |
| 臺大學術典藏 |
2021-07-06T05:41:32Z |
Clinical pharmacy service and international collaboration: Model and experience from a medical center in Taiwan
|
Wu C.-C.; Lin F.-J.; Lin S.-W.; Ho Y.-F.; Huang C.-F.; Shen L.-J.; FE-LIN LIN WU |
| 臺大學術典藏 |
2021-07-05T07:06:05Z |
Clinical pharmacy service and international collaboration: Model and experience from a medical center in Taiwan
|
Wu C.-C.; Lin F.-J.; Lin S.-W.; Ho Y.-F.; CHIH-FEN HUANG; Shen L.-J.; Wu F.-L.L. |
| 臺大學術典藏 |
2021-07-05T05:30:50Z |
Clinical pharmacy service and international collaboration: Model and experience from a medical center in Taiwan
|
CHIEN-CHIH WU; Lin F.-J.; Lin S.-W.; Ho Y.-F.; Huang C.-F.; Shen L.-J.; Wu F.-L.L. |
| 臺大學術典藏 |
2021-07-05T05:30:49Z |
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
|
Shao C.-H.; Tai C.-H.; Lin F.-J.; CHIEN-CHIH WU; Wang J.-T.; Wang C.-C. |
| 臺大學術典藏 |
2021-07-05T05:30:48Z |
Nephrotoxicity of teicoplanin-based combination therapy: Focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams
|
Tai C.-H.; Shao C.-H.; Wang C.-C.; Lin F.-J.; Wang J.-T.; CHIEN-CHIH WU |
| 臺大學術典藏 |
2021-07-05T01:12:16Z |
Comparative effectiveness and safety of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome or percutaneous coronary intervention
|
Wang Y.-H.;Kao H.-L.;Chi-Chuan Wang;Lin S.-Y.;Lin F.-J.; Wang Y.-H.; Kao H.-L.; CHI-CHUAN WANG; Lin S.-Y.; Lin F.-J. |
| 臺大學術典藏 |
2021-07-05T01:12:15Z |
Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study
|
Wei Y.;Lin F.-J.;Lin S.-Y.;Chi-Chuan Wang; Wei Y.; Lin F.-J.; Lin S.-Y.; CHI-CHUAN WANG |
| 臺大學術典藏 |
2021-07-05T01:12:13Z |
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan
|
Huang K.; Lin F.-J.; Ou H.-T.; Hsu C.-N.; Huang L.-Y.; CHI-CHUAN WANG; Toh S. |
| 臺大學術典藏 |
2021-07-05T01:12:12Z |
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation and valvular heart disease
|
Li H.-J.; Lin S.-Y.; Lin F.-J.; Hung C.-S.; CHI-CHUAN WANG |
| 臺大學術典藏 |
2021-07-05T01:12:12Z |
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
|
Shao C.-H.; Tai C.-H.; Lin F.-J.; Wu C.-C.; Wang J.-T.; CHI-CHUAN WANG |
| 臺大學術典藏 |
2021-07-05T01:12:11Z |
Risk of Intracranial Hemorrhage With Concomitant Use of Antidepressants and Nonsteroidal Anti-inflammatory Drugs: A Nested Case-Control Study
|
Hou P.-C.; Lin F.-J.; Lin S.-Y.; Hwang T.-J.; CHI-CHUAN WANG |
| 臺大學術典藏 |
2021-06-04T05:34:39Z |
Clinical pharmacy service and international collaboration: Model and experience from a medical center in Taiwan
|
Wu C.-C.;Lin F.-J.;Lin S.-W.;Ho Y.-F.;Huang C.-F.;Li-Jiuan Shen;Wu F.-L.L.; Wu C.-C.; Lin F.-J.; Lin S.-W.; Ho Y.-F.; Huang C.-F.; LI-JIUAN SHEN; Wu F.-L.L. |
| 臺大學術典藏 |
2021-05-07T06:47:52Z |
Blood NfL: A biomarker for disease severity and progression in Parkinson disease
|
Lin C.-H.;Li C.-H.;Kai-Chien Yang;Lin F.-J.;Wu C.-C.;Chieh J.-J.;Chiu M.-J.; Lin C.-H.; Li C.-H.; KAI-CHIEN YANG; Lin F.-J.; Wu C.-C.; Chieh J.-J.; Chiu M.-J. |
| 臺大學術典藏 |
2021-03-18T08:54:16Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:13Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-03-18T08:54:11Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; YEN-WEN WU; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C. |
| 臺大學術典藏 |
2021-03-18T08:54:00Z |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li Y.-H.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; YEN-WEN WU; Hsieh I.-C.; Lin T.-H.; Sheu W.H.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2021-01-15T02:46:17Z |
Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
|
Su C.-Y.; Shen L.-J.; SONG-CHOU HSIEH; Lin L.-Y.; Lin F.-J. |
| 國立成功大學 |
2021 |
Fasting triglycerides is a risk factor for cardiovascular event in T-SPARCLE registry in Taiwan
|
Chen, Chen C.-Y.;Tseng, W.-K.;Lin, F.-J.;Wu, Y.-W.;Lin, T.-H.;Li, Y.-H.;Sheu, W.H.-H.;Huang, L.-C.;Hsieh, I.C.;Pan, W.-H.;Yeh, H.I.;Wu, C.-C.;Yin, W.-H.;Chen, J.-W. |
